Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma

Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma

Weitere Versionen anzeigen (1)

<p><strong>Background</strong></p> <p>Asthma affects 350 million people worldwide including 45% to 70% with mild disease. Treatment is mainly with inhalers containing beta₂‐agonists, typically taken as required to relieve bronchospasm, and inhaled corticosteroids (ICS)...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Crossingham, I, Turner, S, Ramakrishnan, S, Fries, A, Gowell, M, Yasmin, F, Richardson, R, Webb, P, O'Boyle, E, Hinks, TSC
Format:	Journal article
Sprache:	English
Veröffentlicht:	Wiley 2021

Ähnliche Einträge

Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma
von: Crossingham, I, et al.
Veröffentlicht: (2020)

Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review
von: Crossingham, I, et al.
Veröffentlicht: (2021)

Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids while on monoclonal antibody therapy: protocol for a prospective observational study (BOOST)
von: Howell, I, et al.
Veröffentlicht: (2023)

A proof-of-concept scale to predict asthma attacks: the OxfoRd Asthma attaCk risk ScaLE (ORACLE)
von: Couillard, S, et al.
Veröffentlicht: (2021)

Azithromycin for mild-to-moderate COVID-19 - Authors' reply
von: Hinks, TSC
Veröffentlicht: (2021)

Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma–COPD overlap syndrome
von: Lee SY, et al.
Veröffentlicht: (2016-11-01)

COMPARISON OF ORAL AND LARYNGEAL FINDINGS OF ASTHMA PATIENTS USING DIFFERENT DRY POWDER INHALER DEVICES CONTAINING STEROID AND BETA AGONISTS
von: Fahrettin Talay, et al.
Veröffentlicht: (2013-09-01)

Pharmacokinetic optimisation of inhaled steroid therapy in asthma.
von: Pavord, I, et al.
Veröffentlicht: (1993)

Inhaled Steroids: First Line Treatment of Adult Asthma
von: André Cartier
Veröffentlicht: (1995-01-01)

Patterns and Determinants of Compliance with Inhaled Steroids in Adults with Asthma
von: Yves Lacasse, et al.
Veröffentlicht: (2005-01-01)

Inhaled steroids for asthma after emergency department discharge
von: John Z Hillenkamp, et al.
Veröffentlicht: (2020-05-01)

Treatment options in type-2 low asthma
von: Hinks, TSC, et al.
Veröffentlicht: (2020)

Efficacy of Inhaled Steroid Over Systemic Steroid in Stabilizing Acute Asthma in Emergency Room
von: B.V. Siva Vara Prasad Rao, et al.
Veröffentlicht: (2025-02-01)

Role of Inhaled Steroids in Vascular Airway Remodelling in Asthma and COPD
von: Alfredo Chetta, et al.
Veröffentlicht: (2012-01-01)

Cough and asthma: the role of inhaled corticosteroids and ß2-agonists
von: Mario Cazzola, et al.
Veröffentlicht: (2008-02-01)

Refractoriness to inhaled sodium metabisulphite in subjects with mild asthma.
von: Pavord, I, et al.
Veröffentlicht: (1994)

Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST
von: McKeever, T, et al.
Veröffentlicht: (2018)

Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST
von: Tricia McKeever, et al.
Veröffentlicht: (2018-12-01)

Real-world efficacy and problems of once-daily use of inhaled steroid (fluticasone furoate) combined with long-acting beta-2 agonist (vilanterol) in Japanese patients with asthma
von: Akira Umeda, et al.
Veröffentlicht: (2019-01-01)

Reduction of Eosinophils in Small Airways by Inhaled Steroids is Insufficient in Patients with Adult Asthma
von: Hiroshi Tanaka, et al.
Veröffentlicht: (2006-01-01)

Effect of 443c81, an inhaled mu-opioid receptor agonist in asthma.
von: Pavord, I, et al.
Veröffentlicht: (1994)

The Effect of Inhaled Beta-2 Agonists on Heart Rate in Patients With Asthma: Sensor-Based Observational Study
von: Rishi Jayant Khusial, et al.
Veröffentlicht: (2024-12-01)

The Relationship among the Inspiratory Muscle Strength, the Perception of Dyspnea and Inhaled Beta2-Agonists in Patients with Asthma
von: Paltiel Weiner, et al.
Veröffentlicht: (2002-01-01)

Non-typeable Haemophilus influenzae airways infection: the next treatable trait in asthma?
von: Hinks, TSC, et al.
Veröffentlicht: (2022)

Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)
von: Imran Howell, et al.
Veröffentlicht: (2023-06-01)

Asthma control in patients receiving inhaled corticosteroid and long-acting beta<sub>2</sub>-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation
von: Nicolini Gabriele, et al.
Veröffentlicht: (2011-07-01)

Is there a role for type 2 CD8+ T cells in patients with steroid-resistant asthma?
von: Gelfand, EW, et al.
Veröffentlicht: (2019)

Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma
von: Scaparrotta Alessandra, et al.
Veröffentlicht: (2012-07-01)

Inhaled corticosteroids and leukotriene modifiers as mono-therapy for mild persistent asthma
von: Amr Radwan, et al.
Veröffentlicht: (2013-07-01)

Perceptions and use of inhaled steroids in adults after discharge from hospital with acute asthma
von: Calder, C, et al.
Veröffentlicht: (2000)

Beta 2-agonists in asthma.
von: Britton, J, et al.
Veröffentlicht: (1991)

Boosting MAIT cells as immunotherapy: Context is everything
von: Hinks, TSC
Veröffentlicht: (2020)

A Fully Decentralized Randomized Controlled Study of As-Needed Albuterol–Budesonide Fixed-Dose Inhaler in Mild Asthma: The BATURA Study Design
von: LaForce C, et al.
Veröffentlicht: (2024-08-01)

Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study
von: Toni Fernández-Sánchez, et al.
Veröffentlicht: (2022-04-01)

Corticosteroid plus β2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis
von: Gang Wang, et al.
Veröffentlicht: (2017-12-01)

Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
von: Yang HH, et al.
Veröffentlicht: (2017-08-01)

Beware the inhaled steroids or corticophobia?
von: Dimos Gidaris, et al.
Veröffentlicht: (2021-02-01)

ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma—implications for COVID-19
von: Bradding, P, et al.
Veröffentlicht: (2020)

Montelukast as Add-On Therapy with Inhaled Corticosteroids or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (The RADAR Trial)
von: Paul K Keith, et al.
Veröffentlicht: (2009-01-01)

Beta2-Agonists and Asthma in Children
von: Guy Lapierre
Veröffentlicht: (1995-01-01)